Clover Health Investments's ROE % for the quarter that ended in Mar. 2026 was 33.06%. Clover Health Investments's PB Ratio for the quarter that ended in Mar. 2026 was N/A.
Clover Health Investments's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was N/A.
Clover Health Investments ROE % Adjusted to Book Value Related Terms
Clover Health Investments ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Clover Health Investments's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clover Health Investments ROE % Adjusted to Book Value Chart
BSP:CLOV34 vs PGNY, ALHC, PFHO: ROE % Adjusted to Book Value Comparison
For the Healthcare Plans subindustry, Clover Health Investments's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clover Health Investments ROE % Adjusted to Book Value vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Clover Health Investments's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Clover Health Investments's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 0.00% mean?
Clover Health Investments (BSP:CLOV34) has a ROE % Adjusted to Book Value of 0.00% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Clover Health Investments and its competitors.
Is Clover Health Investments' ROE % Adjusted to Book Value too high?
Clover Health Investments' current ROE % Adjusted to Book Value is 0.00%. Overall, Clover Health Investments has a GF Score™ of 48/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clover Health Investments' ROE % Adjusted to Book Value compare to PGNY and ALHC?
Clover Health Investments' ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Plans company?
A good ROE % Adjusted to Book Value depends on the Healthcare Plans industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Clover Health Investments and its competitors. Clover Health Investments's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clover Health Investments stock overvalued right now?
Based on GuruFocus' analysis, Clover Health Investments (BSP:CLOV34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$20.49, compared to a current price of R$26.19 — trading 27.8% above its estimated fair value. The current ROE % Adjusted to Book Value is 0.00%. Clover Health Investments' overall GF Score™ is 48/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Clover Health Investments (BSP:CLOV34), the current ROE % Adjusted to Book Value is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clover Health Investments (BSP:CLOV34) Overvalued in 2026?
Based on GuruFocus' analysis, Clover Health Investments stock appears to be overvalued.
The current stock price of R$26.19 is trading 27.8% above its estimated GF Value™ of R$20.49.
GuruFocus considers Clover Health Investments to be Modestly Overvalued.
Key valuation signals for BSP:CLOV34:
ROE % Adjusted to Book Value: 0.00%
GF Value™: R$20.49 vs. price of R$26.19 (27.8% above fair value)
No single metric tells the full story. See the BSP:CLOV34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
48GF Score
Get the complete analysis for BSP:CLOV34
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:CLOV34 has been successfully added to your 
